Summary

The global Therapeutic Antibody Discovery Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Therapeutic antibody discovery services are specialized laboratory services that focus on the identification and development of novel antibodies for therapeutic applications. These services utilize advanced techniques such as hybridoma technology, phage display, or single-cell sequencing to generate antibodies that specifically target disease-related antigens or proteins. Therapeutic antibody discovery services typically involve screening of large antibody libraries, antibody engineering, and optimization to enhance binding affinity, specificity, and functional characteristics to develop effective and targeted therapeutic antibodies.
The industry trend for therapeutic antibody discovery services is experiencing significant growth due to the increasing demand for antibody-based therapeutics. The advancements in biotechnology and computational biology have accelerated the discovery and development of antibodies, leading to more targeted and effective therapeutic strategies. With the expanding understanding of disease mechanisms and the constant need for new treatment options, therapeutic antibody discovery services are crucial for identifying and developing innovative and targeted antibody-based therapeutics. Furthermore, the trend towards personalized and precision medicine has fueled the demand for therapeutic antibody discovery services, as they enable the development of targeted treatments tailored to individual patients" needs. Overall, the future of therapeutic antibody discovery services looks bright as they continue to play a vital role in the development of novel and effective antibody-based therapeutics.
The global Therapeutic Antibody Discovery Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Biocytogen
Charles River Laboratories
Abcam
Alloy Therapeutics
Creative Biolabs
Twist Bioscience
Rapid Novor
Curia
AlivaMab Biologics
Integrated DNA Technologies
Antibody Solutions
Eurofins Discovery
GenScript
Evotec
Aurigene Pharmaceutical Services
Yumab
Creative Bioarray
CD ComputaBio
Biomolecular Discovery Services
ProteoGenix
Sichuan NB Biolab
Viva Biotech
SAFE Pharmaceutical Technology
Shanghai Medicilon
WuXi Biologics
XtalPi
Detaibio
Cusabio
Segment by Type
Discovery of CAR-T Antibody Drugs
Discovery of Monoclonal Antibody Drugs
Discovery of ADC Antibody Drugs
Others
Segment by Application
Biotechnology
Medical
University
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Therapeutic Antibody Discovery Services market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Therapeutic Antibody Discovery Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Discovery of CAR-T Antibody Drugs
1.2.3 Discovery of Monoclonal Antibody Drugs
1.2.4 Discovery of ADC Antibody Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Antibody Discovery Services Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Therapeutic Antibody Discovery Services Market Share by Revenue, by Region (2021-2026)
2.4 Global Therapeutic Antibody Discovery Services Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Therapeutic Antibody Discovery Services Market Size and Prospective (2021-2032)
2.5.2 Europe Therapeutic Antibody Discovery Services Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Therapeutic Antibody Discovery Services Market Size and Prospective (2021-2032)
2.5.4 Latin America Therapeutic Antibody Discovery Services Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Therapeutic Antibody Discovery Services Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Therapeutic Antibody Discovery Services Historical Market Size by Type (2021-2026)
3.2 Global Therapeutic Antibody Discovery Services Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Therapeutic Antibody Discovery Services
4 Breakdown Data by Application
4.1 Global Therapeutic Antibody Discovery Services Historical Market Size by Application (2021-2026)
4.2 Global Therapeutic Antibody Discovery Services Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Therapeutic Antibody Discovery Services Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Therapeutic Antibody Discovery Services Players by Revenue (2021-2026)
5.1.2 Global Therapeutic Antibody Discovery Services Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Therapeutic Antibody Discovery Services Revenue
5.4 Global Therapeutic Antibody Discovery Services Market Concentration Analysis
5.4.1 Global Therapeutic Antibody Discovery Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Therapeutic Antibody Discovery Services Revenue in 2025
5.5 Global Key Players of Therapeutic Antibody Discovery Services Head Offices and Areas Served
5.6 Global Key Players of Therapeutic Antibody Discovery Services, Product and Application
5.7 Global Key Players of Therapeutic Antibody Discovery Services, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Therapeutic Antibody Discovery Services Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Therapeutic Antibody Discovery Services Market Size by Type (2021-2026)
6.1.2.2 North America Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Therapeutic Antibody Discovery Services Market Size by Application (2021-2026)
6.1.3.2 North America Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
6.1.4 North America Therapeutic Antibody Discovery Services Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Therapeutic Antibody Discovery Services Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Therapeutic Antibody Discovery Services Market Size by Type (2021-2026)
6.2.2.2 Europe Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Therapeutic Antibody Discovery Services Market Size by Application (2021-2026)
6.2.3.2 Europe Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
6.2.4 Europe Therapeutic Antibody Discovery Services Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Therapeutic Antibody Discovery Services Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Therapeutic Antibody Discovery Services Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Therapeutic Antibody Discovery Services Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Therapeutic Antibody Discovery Services Market Size by Type (2021-2026)
6.4.2.2 Latin America Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Therapeutic Antibody Discovery Services Market Size by Application (2021-2026)
6.4.3.2 Latin America Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
6.4.4 Latin America Therapeutic Antibody Discovery Services Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Therapeutic Antibody Discovery Services Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Therapeutic Antibody Discovery Services Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Biocytogen
7.1.1 Biocytogen Company Details
7.1.2 Biocytogen Business Overview
7.1.3 Biocytogen Therapeutic Antibody Discovery Services Introduction
7.1.4 Biocytogen Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.1.5 Biocytogen Recent Development
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Company Details
7.2.2 Charles River Laboratories Business Overview
7.2.3 Charles River Laboratories Therapeutic Antibody Discovery Services Introduction
7.2.4 Charles River Laboratories Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.2.5 Charles River Laboratories Recent Development
7.3 Abcam
7.3.1 Abcam Company Details
7.3.2 Abcam Business Overview
7.3.3 Abcam Therapeutic Antibody Discovery Services Introduction
7.3.4 Abcam Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.3.5 Abcam Recent Development
7.4 Alloy Therapeutics
7.4.1 Alloy Therapeutics Company Details
7.4.2 Alloy Therapeutics Business Overview
7.4.3 Alloy Therapeutics Therapeutic Antibody Discovery Services Introduction
7.4.4 Alloy Therapeutics Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.4.5 Alloy Therapeutics Recent Development
7.5 Creative Biolabs
7.5.1 Creative Biolabs Company Details
7.5.2 Creative Biolabs Business Overview
7.5.3 Creative Biolabs Therapeutic Antibody Discovery Services Introduction
7.5.4 Creative Biolabs Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.5.5 Creative Biolabs Recent Development
7.6 Twist Bioscience
7.6.1 Twist Bioscience Company Details
7.6.2 Twist Bioscience Business Overview
7.6.3 Twist Bioscience Therapeutic Antibody Discovery Services Introduction
7.6.4 Twist Bioscience Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.6.5 Twist Bioscience Recent Development
7.7 Rapid Novor
7.7.1 Rapid Novor Company Details
7.7.2 Rapid Novor Business Overview
7.7.3 Rapid Novor Therapeutic Antibody Discovery Services Introduction
7.7.4 Rapid Novor Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.7.5 Rapid Novor Recent Development
7.8 Curia
7.8.1 Curia Company Details
7.8.2 Curia Business Overview
7.8.3 Curia Therapeutic Antibody Discovery Services Introduction
7.8.4 Curia Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.8.5 Curia Recent Development
7.9 AlivaMab Biologics
7.9.1 AlivaMab Biologics Company Details
7.9.2 AlivaMab Biologics Business Overview
7.9.3 AlivaMab Biologics Therapeutic Antibody Discovery Services Introduction
7.9.4 AlivaMab Biologics Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.9.5 AlivaMab Biologics Recent Development
7.10 Integrated DNA Technologies
7.10.1 Integrated DNA Technologies Company Details
7.10.2 Integrated DNA Technologies Business Overview
7.10.3 Integrated DNA Technologies Therapeutic Antibody Discovery Services Introduction
7.10.4 Integrated DNA Technologies Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.10.5 Integrated DNA Technologies Recent Development
7.11 Antibody Solutions
7.11.1 Antibody Solutions Company Details
7.11.2 Antibody Solutions Business Overview
7.11.3 Antibody Solutions Therapeutic Antibody Discovery Services Introduction
7.11.4 Antibody Solutions Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.11.5 Antibody Solutions Recent Development
7.12 Eurofins Discovery
7.12.1 Eurofins Discovery Company Details
7.12.2 Eurofins Discovery Business Overview
7.12.3 Eurofins Discovery Therapeutic Antibody Discovery Services Introduction
7.12.4 Eurofins Discovery Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.12.5 Eurofins Discovery Recent Development
7.13 GenScript
7.13.1 GenScript Company Details
7.13.2 GenScript Business Overview
7.13.3 GenScript Therapeutic Antibody Discovery Services Introduction
7.13.4 GenScript Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.13.5 GenScript Recent Development
7.14 Evotec
7.14.1 Evotec Company Details
7.14.2 Evotec Business Overview
7.14.3 Evotec Therapeutic Antibody Discovery Services Introduction
7.14.4 Evotec Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.14.5 Evotec Recent Development
7.15 Aurigene Pharmaceutical Services
7.15.1 Aurigene Pharmaceutical Services Company Details
7.15.2 Aurigene Pharmaceutical Services Business Overview
7.15.3 Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Introduction
7.15.4 Aurigene Pharmaceutical Services Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.15.5 Aurigene Pharmaceutical Services Recent Development
7.16 Yumab
7.16.1 Yumab Company Details
7.16.2 Yumab Business Overview
7.16.3 Yumab Therapeutic Antibody Discovery Services Introduction
7.16.4 Yumab Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.16.5 Yumab Recent Development
7.17 Creative Bioarray
7.17.1 Creative Bioarray Company Details
7.17.2 Creative Bioarray Business Overview
7.17.3 Creative Bioarray Therapeutic Antibody Discovery Services Introduction
7.17.4 Creative Bioarray Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.17.5 Creative Bioarray Recent Development
7.18 CD ComputaBio
7.18.1 CD ComputaBio Company Details
7.18.2 CD ComputaBio Business Overview
7.18.3 CD ComputaBio Therapeutic Antibody Discovery Services Introduction
7.18.4 CD ComputaBio Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.18.5 CD ComputaBio Recent Development
7.19 Biomolecular Discovery Services
7.19.1 Biomolecular Discovery Services Company Details
7.19.2 Biomolecular Discovery Services Business Overview
7.19.3 Biomolecular Discovery Services Therapeutic Antibody Discovery Services Introduction
7.19.4 Biomolecular Discovery Services Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.19.5 Biomolecular Discovery Services Recent Development
7.20 ProteoGenix
7.20.1 ProteoGenix Company Details
7.20.2 ProteoGenix Business Overview
7.20.3 ProteoGenix Therapeutic Antibody Discovery Services Introduction
7.20.4 ProteoGenix Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.20.5 ProteoGenix Recent Development
7.21 Sichuan NB Biolab
7.21.1 Sichuan NB Biolab Company Details
7.21.2 Sichuan NB Biolab Business Overview
7.21.3 Sichuan NB Biolab Therapeutic Antibody Discovery Services Introduction
7.21.4 Sichuan NB Biolab Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.21.5 Sichuan NB Biolab Recent Development
7.22 Viva Biotech
7.22.1 Viva Biotech Company Details
7.22.2 Viva Biotech Business Overview
7.22.3 Viva Biotech Therapeutic Antibody Discovery Services Introduction
7.22.4 Viva Biotech Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.22.5 Viva Biotech Recent Development
7.23 SAFE Pharmaceutical Technology
7.23.1 SAFE Pharmaceutical Technology Company Details
7.23.2 SAFE Pharmaceutical Technology Business Overview
7.23.3 SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Introduction
7.23.4 SAFE Pharmaceutical Technology Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.23.5 SAFE Pharmaceutical Technology Recent Development
7.24 Shanghai Medicilon
7.24.1 Shanghai Medicilon Company Details
7.24.2 Shanghai Medicilon Business Overview
7.24.3 Shanghai Medicilon Therapeutic Antibody Discovery Services Introduction
7.24.4 Shanghai Medicilon Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.24.5 Shanghai Medicilon Recent Development
7.25 WuXi Biologics
7.25.1 WuXi Biologics Company Details
7.25.2 WuXi Biologics Business Overview
7.25.3 WuXi Biologics Therapeutic Antibody Discovery Services Introduction
7.25.4 WuXi Biologics Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.25.5 WuXi Biologics Recent Development
7.26 XtalPi
7.26.1 XtalPi Company Details
7.26.2 XtalPi Business Overview
7.26.3 XtalPi Therapeutic Antibody Discovery Services Introduction
7.26.4 XtalPi Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.26.5 XtalPi Recent Development
7.27 Detaibio
7.27.1 Detaibio Company Details
7.27.2 Detaibio Business Overview
7.27.3 Detaibio Therapeutic Antibody Discovery Services Introduction
7.27.4 Detaibio Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.27.5 Detaibio Recent Development
7.28 Cusabio
7.28.1 Cusabio Company Details
7.28.2 Cusabio Business Overview
7.28.3 Cusabio Therapeutic Antibody Discovery Services Introduction
7.28.4 Cusabio Revenue in Therapeutic Antibody Discovery Services Business (2021-2026)
7.28.5 Cusabio Recent Development
8 Therapeutic Antibody Discovery Services Market Dynamics
8.1 Therapeutic Antibody Discovery Services Industry Trends
8.2 Therapeutic Antibody Discovery Services Market Drivers
8.3 Therapeutic Antibody Discovery Services Market Challenges
8.4 Therapeutic Antibody Discovery Services Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Therapeutic Antibody Discovery Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Therapeutic Antibody Discovery Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Therapeutic Antibody Discovery Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Therapeutic Antibody Discovery Services Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Therapeutic Antibody Discovery Services Revenue Share by Region (2021-2026)
Table 6. Global Therapeutic Antibody Discovery Services Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Therapeutic Antibody Discovery Services Revenue Share Forecast by Region (2027-2032)
Table 8. Global Therapeutic Antibody Discovery Services Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Therapeutic Antibody Discovery Services Market Share by Revenue, by Type (2021-2026)
Table 10. Global Therapeutic Antibody Discovery Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Therapeutic Antibody Discovery Services Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Therapeutic Antibody Discovery Services Market Share by Revenue, by Application (2021-2026)
Table 15. Global Therapeutic Antibody Discovery Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Therapeutic Antibody Discovery Services Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Therapeutic Antibody Discovery Services Applications
Table 18. Global Therapeutic Antibody Discovery Services Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Therapeutic Antibody Discovery Services Market Share by Players (2021-2026)
Table 20. Global Top Therapeutic Antibody Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibody Discovery Services as of 2025)
Table 21. Ranking of Global Top Therapeutic Antibody Discovery Services Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Therapeutic Antibody Discovery Services Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Therapeutic Antibody Discovery Services, Headquarters and Area Served
Table 24. Global Key Players of Therapeutic Antibody Discovery Services, Product and Application
Table 25. Global Key Players of Therapeutic Antibody Discovery Services, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Therapeutic Antibody Discovery Services Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Therapeutic Antibody Discovery Services Market Share by Revenue, by Company (2021-2026)
Table 29. North America Therapeutic Antibody Discovery Services Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Therapeutic Antibody Discovery Services Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Therapeutic Antibody Discovery Services Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Therapeutic Antibody Discovery Services Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Therapeutic Antibody Discovery Services Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Therapeutic Antibody Discovery Services Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Therapeutic Antibody Discovery Services Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Therapeutic Antibody Discovery Services Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Therapeutic Antibody Discovery Services Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Therapeutic Antibody Discovery Services Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Therapeutic Antibody Discovery Services Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (US$ Million)
Table 47. Biocytogen Company Details
Table 48. Biocytogen Business Overview
Table 49. Biocytogen Therapeutic Antibody Discovery Services Product
Table 50. Biocytogen Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 51. Biocytogen Recent Development
Table 52. Charles River Laboratories Company Details
Table 53. Charles River Laboratories Business Overview
Table 54. Charles River Laboratories Therapeutic Antibody Discovery Services Product
Table 55. Charles River Laboratories Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 56. Charles River Laboratories Recent Development
Table 57. Abcam Company Details
Table 58. Abcam Business Overview
Table 59. Abcam Therapeutic Antibody Discovery Services Product
Table 60. Abcam Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 61. Abcam Recent Development
Table 62. Alloy Therapeutics Company Details
Table 63. Alloy Therapeutics Business Overview
Table 64. Alloy Therapeutics Therapeutic Antibody Discovery Services Product
Table 65. Alloy Therapeutics Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 66. Alloy Therapeutics Recent Development
Table 67. Creative Biolabs Company Details
Table 68. Creative Biolabs Business Overview
Table 69. Creative Biolabs Therapeutic Antibody Discovery Services Product
Table 70. Creative Biolabs Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 71. Creative Biolabs Recent Development
Table 72. Twist Bioscience Company Details
Table 73. Twist Bioscience Business Overview
Table 74. Twist Bioscience Therapeutic Antibody Discovery Services Product
Table 75. Twist Bioscience Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 76. Twist Bioscience Recent Development
Table 77. Rapid Novor Company Details
Table 78. Rapid Novor Business Overview
Table 79. Rapid Novor Therapeutic Antibody Discovery Services Product
Table 80. Rapid Novor Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 81. Rapid Novor Recent Development
Table 82. Curia Company Details
Table 83. Curia Business Overview
Table 84. Curia Therapeutic Antibody Discovery Services Product
Table 85. Curia Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 86. Curia Recent Development
Table 87. AlivaMab Biologics Company Details
Table 88. AlivaMab Biologics Business Overview
Table 89. AlivaMab Biologics Therapeutic Antibody Discovery Services Product
Table 90. AlivaMab Biologics Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 91. AlivaMab Biologics Recent Development
Table 92. Integrated DNA Technologies Company Details
Table 93. Integrated DNA Technologies Business Overview
Table 94. Integrated DNA Technologies Therapeutic Antibody Discovery Services Product
Table 95. Integrated DNA Technologies Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 96. Integrated DNA Technologies Recent Development
Table 97. Antibody Solutions Company Details
Table 98. Antibody Solutions Business Overview
Table 99. Antibody Solutions Therapeutic Antibody Discovery Services Product
Table 100. Antibody Solutions Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 101. Antibody Solutions Recent Development
Table 102. Eurofins Discovery Company Details
Table 103. Eurofins Discovery Business Overview
Table 104. Eurofins Discovery Therapeutic Antibody Discovery Services Product
Table 105. Eurofins Discovery Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 106. Eurofins Discovery Recent Development
Table 107. GenScript Company Details
Table 108. GenScript Business Overview
Table 109. GenScript Therapeutic Antibody Discovery Services Product
Table 110. GenScript Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 111. GenScript Recent Development
Table 112. Evotec Company Details
Table 113. Evotec Business Overview
Table 114. Evotec Therapeutic Antibody Discovery Services Product
Table 115. Evotec Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 116. Evotec Recent Development
Table 117. Aurigene Pharmaceutical Services Company Details
Table 118. Aurigene Pharmaceutical Services Business Overview
Table 119. Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Product
Table 120. Aurigene Pharmaceutical Services Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 121. Aurigene Pharmaceutical Services Recent Development
Table 122. Yumab Company Details
Table 123. Yumab Business Overview
Table 124. Yumab Therapeutic Antibody Discovery Services Product
Table 125. Yumab Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 126. Yumab Recent Development
Table 127. Creative Bioarray Company Details
Table 128. Creative Bioarray Business Overview
Table 129. Creative Bioarray Therapeutic Antibody Discovery Services Product
Table 130. Creative Bioarray Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 131. Creative Bioarray Recent Development
Table 132. CD ComputaBio Company Details
Table 133. CD ComputaBio Business Overview
Table 134. CD ComputaBio Therapeutic Antibody Discovery Services Product
Table 135. CD ComputaBio Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 136. CD ComputaBio Recent Development
Table 137. Biomolecular Discovery Services Company Details
Table 138. Biomolecular Discovery Services Business Overview
Table 139. Biomolecular Discovery Services Therapeutic Antibody Discovery Services Product
Table 140. Biomolecular Discovery Services Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 141. Biomolecular Discovery Services Recent Development
Table 142. ProteoGenix Company Details
Table 143. ProteoGenix Business Overview
Table 144. ProteoGenix Therapeutic Antibody Discovery Services Product
Table 145. ProteoGenix Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 146. ProteoGenix Recent Development
Table 147. Sichuan NB Biolab Company Details
Table 148. Sichuan NB Biolab Business Overview
Table 149. Sichuan NB Biolab Therapeutic Antibody Discovery Services Product
Table 150. Sichuan NB Biolab Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 151. Sichuan NB Biolab Recent Development
Table 152. Viva Biotech Company Details
Table 153. Viva Biotech Business Overview
Table 154. Viva Biotech Therapeutic Antibody Discovery Services Product
Table 155. Viva Biotech Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 156. Viva Biotech Recent Development
Table 157. SAFE Pharmaceutical Technology Company Details
Table 158. SAFE Pharmaceutical Technology Business Overview
Table 159. SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Product
Table 160. SAFE Pharmaceutical Technology Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 161. SAFE Pharmaceutical Technology Recent Development
Table 162. Shanghai Medicilon Company Details
Table 163. Shanghai Medicilon Business Overview
Table 164. Shanghai Medicilon Therapeutic Antibody Discovery Services Product
Table 165. Shanghai Medicilon Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 166. Shanghai Medicilon Recent Development
Table 167. WuXi Biologics Company Details
Table 168. WuXi Biologics Business Overview
Table 169. WuXi Biologics Therapeutic Antibody Discovery Services Product
Table 170. WuXi Biologics Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 171. WuXi Biologics Recent Development
Table 172. XtalPi Company Details
Table 173. XtalPi Business Overview
Table 174. XtalPi Therapeutic Antibody Discovery Services Product
Table 175. XtalPi Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 176. XtalPi Recent Development
Table 177. Detaibio Company Details
Table 178. Detaibio Business Overview
Table 179. Detaibio Therapeutic Antibody Discovery Services Product
Table 180. Detaibio Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 181. Detaibio Recent Development
Table 182. Cusabio Company Details
Table 183. Cusabio Business Overview
Table 184. Cusabio Therapeutic Antibody Discovery Services Product
Table 185. Cusabio Revenue in Therapeutic Antibody Discovery Services Business (2021-2026) & (US$ Million)
Table 186. Cusabio Recent Development
Table 187. Therapeutic Antibody Discovery Services Market Trends
Table 188. Therapeutic Antibody Discovery Services Market Drivers
Table 189. Therapeutic Antibody Discovery Services Market Challenges
Table 190. Therapeutic Antibody Discovery Services Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources


List of Figures
Figure 1. Therapeutic Antibody Discovery Services Product Picture
Figure 2. Global Therapeutic Antibody Discovery Services Market Share by Type: 2025 vs 2032
Figure 3. Discovery of CAR-T Antibody Drugs Features
Figure 4. Discovery of Monoclonal Antibody Drugs Features
Figure 5. Discovery of ADC Antibody Drugs Features
Figure 6. Others Features
Figure 7. Global Therapeutic Antibody Discovery Services Market Share by Application: 2025 vs 2032
Figure 8. Biotechnology
Figure 9. Medical
Figure 10. University
Figure 11. Others
Figure 12. Therapeutic Antibody Discovery Services Report Years Considered
Figure 13. Global Therapeutic Antibody Discovery Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 14. Global Therapeutic Antibody Discovery Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Therapeutic Antibody Discovery Services Market Share by Revenue, by Region: 2021 vs 2025
Figure 16. North America Therapeutic Antibody Discovery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Europe Therapeutic Antibody Discovery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Asia-Pacific Therapeutic Antibody Discovery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Latin America Therapeutic Antibody Discovery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Middle East & Africa Therapeutic Antibody Discovery Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Global Therapeutic Antibody Discovery Services Market Share by Players in 2025
Figure 22. Global Top Therapeutic Antibody Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Antibody Discovery Services as of 2025)
Figure 23. The Top 10 and 5 Players Market Share by Therapeutic Antibody Discovery Services Revenue in 2025
Figure 24. North America Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
Figure 25. North America Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
Figure 26. Europe Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
Figure 27. Europe Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
Figure 28. Asia-Pacific Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
Figure 29. Asia-Pacific Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
Figure 30. Latin America Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
Figure 31. Latin America Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
Figure 32. Middle East & Africa Therapeutic Antibody Discovery Services Market Share by Type (2021-2026)
Figure 33. Middle East & Africa Therapeutic Antibody Discovery Services Market Share by Application (2021-2026)
Figure 34. Biocytogen Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 35. Charles River Laboratories Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 36. Abcam Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 37. Alloy Therapeutics Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 38. Creative Biolabs Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 39. Twist Bioscience Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 40. Rapid Novor Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 41. Curia Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 42. AlivaMab Biologics Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 43. Integrated DNA Technologies Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 44. Antibody Solutions Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 45. Eurofins Discovery Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 46. GenScript Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 47. Evotec Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 48. Aurigene Pharmaceutical Services Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 49. Yumab Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 50. Creative Bioarray Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 51. CD ComputaBio Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 52. Biomolecular Discovery Services Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 53. ProteoGenix Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 54. Sichuan NB Biolab Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 55. Viva Biotech Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 56. SAFE Pharmaceutical Technology Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 57. Shanghai Medicilon Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 58. WuXi Biologics Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 59. XtalPi Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 60. Detaibio Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 61. Cusabio Revenue Growth Rate in Therapeutic Antibody Discovery Services Business (2021-2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed